Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.

from NYT > Technology https://ift.tt/LiArH0l

Comments

Popular posts from this blog

Prof. M. Ramalinga Raju appointed as Vice Chancellor of JNTU Kakinada

APJAKTU Exam Registration opened - B.Tech (FT,PT) July 2021 (2019 and 2015 scheme)